Jane Street
VIR icon

Jane Street’s Vir Biotechnology VIR Stock Holding History

Jane Street’s Portfolio VIR Stock Details VIR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$577K Buy
+64,400
New +$513K ﹤0.01% 7713
2024
Q3 		– Sell
-60,800
Closed -$541K – 10463
2024
Q2 		$541K Sell
60,800
-5,200
-8% -$49.9K ﹤0.01% 6892
2024
Q1 		$669K Buy
66,000
+3,600
+6% +$36.7K ﹤0.01% 6153
2023
Q4 		$628K Buy
+62,400
New +$570K ﹤0.01% 6372
2023
Q3 		– Sell
-182,600
Closed -$4.48M – 9469
2023
Q2 		$4.48M Buy
182,600
+162,200
+795% +$4.07M ﹤0.01% 2908
2023
Q1 		$475K Sell
20,400
-20,900
-51% -$535K ﹤0.01% 6408
2022
Q4 		$1.05M Sell
41,300
-29,700
-42% -$728K ﹤0.01% 4930
2022
Q3 		$1.37M Buy
71,000
+26,600
+60% +$676K ﹤0.01% 4863
2022
Q2 		$1.13M Sell
44,400
-70,300
-61% -$1.64M ﹤0.01% 5260
2022
Q1 		$2.95M Sell
114,700
-1,100
-0.9% -$32.6K ﹤0.01% 3998
2021
Q4 		$4.85M Buy
115,800
+76,100
+192% +$2.98M ﹤0.01% 2909
2021
Q3 		$1.73M Buy
39,700
+8,000
+25% +$346K ﹤0.01% 4771
2021
Q2 		$1.5M Sell
31,700
-14,500
-31% -$659K ﹤0.01% 4935
2021
Q1 		$2.37M Sell
46,200
-5,600
-11% -$302K ﹤0.01% 3696
2020
Q4 		$1.39M Buy
51,800
+3,700
+8% +$120K ﹤0.01% 4130
2020
Q3 		$1.65M Sell
48,100
-12,100
-20% -$521K ﹤0.01% 3326
2020
Q2 		$2.47M Buy
+60,200
New +$2.02M ﹤0.01% 2767

Other funds holding VIR

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AVM
Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return
SIAU
SB Investment Advisers (UK) London, United Kingdom $7.73B AUM 2.35% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
GP
GSK plc London $599M AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return

Jane Street's VIR Position: Q1 2026 in Review

Jane Street reduced its Vir Biotechnology (VIR) stake by 75% in Q1 2026, selling an estimated $1.58M and leaving 66,344 shares worth $594K. The position accounts for ﹤0.01% of the portfolio, ranked #7647.

Jane Street first reported a position in VIR in Q2 2020 and has held it in 22 quarters since. The position peaked at $5.32M in Q4 2021. 251 funds tracked by Wall St. Rank hold VIR as of Q1 2026.

  • Jane Street held 66,344 shares of Vir Biotechnology worth $594K as of Q1 2026.
  • Jane Street sold 197,662 Vir Biotechnology shares in Q1 2026, an estimated $1.58M.
  • Vir Biotechnology made up ﹤0.01% of Jane Street's portfolio in Q1 2026, its #7647 holding.
  • Jane Street first reported a position in Vir Biotechnology in Q2 2020 and has held it in 22 quarters since.
  • Jane Street's Vir Biotechnology position peaked at $5.32M in Q4 2021.
  • 251 funds tracked by Wall St. Rank held Vir Biotechnology as of Q1 2026.

Based on Jane Street's 13F filing for Q1 2026, filed 12 May 2026.